Missed This Important Session?
If you were unable to attend the session, Glucocorticoid-Induced Osteoporosis Prevention and Treatment: A New ACR Clinical Guideline, during the 2016 ACR/ARHP Annual Meeting, catch it now on SessionSelect.
You Might Also Like
Explore This IssueJanuary 2017
Also By This Author
Susan Bernstein is a freelance medical journalist based in Atlanta.
- Cosman F, de Beur SJ, Le Boff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359–2381.
- Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: A general population perspective. Arthritis Care Res (Hoboken). 2013 Feb;65(2):294-298.
- Van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000 Dec;39(12):1383–1389.
- Kanis JA, Johansson H, Oden A, et al. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int. 2011 Mar;22(3):809–816.